Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage. The Xgeva brand of denosumab is used to prevent bone fractures and other skeletal conditions in people with multiple myeloma, and in people with tumors that have spread to the bone.